The University of Chicago Header Logo

Connection

Rudolph Navari to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Rudolph Navari has written about Drug Evaluation, Preclinical.
Rudolph Navari
Connection Strength
0.077
Drug Evaluation, Preclinical
  1. Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities. Curr Opin Investig Drugs. 2008 Jul; 9(7):774-85.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.